-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2018 to Q1 2023.
- Dianthus Therapeutics, Inc. /DE/ Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $421K, a 17.6% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation, Depletion and Amortization for 2022 was $1.93M, a 4.7% decline from 2021.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation, Depletion and Amortization for 2021 was $2.02M, a 2.12% increase from 2020.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation, Depletion and Amortization for 2020 was $1.98M, a 7.33% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)